Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment
Navigating My Journey (NmJ): A Relapse Prevention Program for Adolescents -- Field Trial
2 other identifiers
interventional
160
1 country
1
Brief Summary
The purpose of this study is to provide a comprehensive evaluation of the new, Navigating my Journey program for adolescents receiving treatment in an outpatient substance abuse center. The primary hypotheses are that, relative to the control condition, Navigating my Journey will be associated with significantly higher motivation, higher self-efficacy, improved relapse coping skills, and lower substance use. The secondary hypotheses are that, relative to the control condition, Navigating my Journey will be associated with increased therapeutic alliances with counselors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Sep 2014
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2014
CompletedFirst Posted
Study publicly available on registry
April 29, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedJuly 27, 2015
June 1, 2015
9 months
April 21, 2014
July 24, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Substance Use Across Time
Participants will be asked how many days in the past 30 days they used a variety of substances, including alcohol. This self report question format is widely used to assess substance use (e.g., the GPRA from CSAT; SAMHSA, 2010).
Baseline, 1 month post baseline, 3 months post baseline, 6 months post baseline
Change in Motivation to Change Across Time
The 32-item University of Rhode Island Change Assessment Questionnaire (URICA; McConnaughy et al., 1983, 1989) will be used to measure motivation to change. It has four 8-item scales (Precontemplation, Contemplation, Action, and Maintenance) that can be combined to create a single Readiness to Change score (C + A + M - PC = Readiness). Participants rate each item 1=Strongly Disagree to 5=Strongly Agree. This scale has good reliability and validity with adolescents (Greenstein et al., 1999).
Baseline, 1 month post baseline, 3 months post baseline, 6 months post baseline
Change in Self-Efficacy Across Time
Drug Avoidance Self-Efficacy Scale (DASES). The DASES (Martin et al., 1995) assesses one's current self-efficacy to resist drug use in hypothetical high-risk situations. The scale contains 16 items, and responses are rated on a 7-point scale ranging from "certainly yes" to "certainly no."
Baseline, 1 month post baseline, 3 months post baseline, 6 months post baseline
Change on the Adolescent Relapse Coping Questionnaire (ARCQ) Across Time
The ARCQ (Myers et al., 2006) assesses "temptation coping responses among adolescents." It begins with a short assessment of appraisal (5 items total) of a situation where peers are drinking and using, followed by 28 items rated between 1 = Definitely would not do or think, through 7 = Definitely would do or think. These 28 items comprise three subscales: Cognitive and behavioral problem solving (e.g., Let your feelings out somehow; alpha = .82); Self-critical thinking (e.g., Criticize or lecture yourself; alpha = .80); and Abstinence-focused coping (e.g., Leave or avoid the situation; alpha = .78).
Baseline, 1 month post baseline, 3 months post baseline, 6 months post baseline
Secondary Outcomes (4)
Change in Therapeutic Alliance Across Time
Baseline, 1 month post baseline, 3 months post baseline, 6 months post baseline
Client Satisfaction
3 months post baseline
Change in Client Engagement/Attendance Across time
1 month post baseline and 6 months post baseline
Counselor Satisfaction
3 months post baseline
Study Arms (2)
Navigating my Journey program
EXPERIMENTALClient participants of counselors who were randomized to the experimental condition will receive the following intervention: The online Navigating my Journey relapse prevention program is an adjunct to outpatient treatment. We will ask client participants to complete at least 12 Navigating my Journey sessions and discuss them with their counselors.
Attention Control
ACTIVE COMPARATORClient participants of counselors who were randomized to the control condition will receive their typical course of counseling and a link to online online health information in PDF form as an attention control.
Interventions
The online relapse prevention program called Navigating my Journey is designed for adolescents who are receiving outpatient treatment for substance abuse. Since the Navigating my Journey program will be available to adolescents 24/7, it is easy for them to access at their convenience. The program functions as an adjunct to treatment and is designed to complement and enhance the work the adolescent does with the counselor during counseling sessions. The core intervention is expected to last for 12 weeks.
Client participants in the control group will receive their typical course of counseling and a link to online online health information in PDF form as an attention control.
Eligibility Criteria
You may qualify if:
- currently meeting with a counselor in the study at least twice per month during the next 3 months
- age 13 to 21
- ability to read and speak English
- have drugs and/or alcohol as their primary or secondary substance used
- have completed detox as necessary
- an active email account.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Inflexxion, Inc.lead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Inflexxion, Inc.
Newton, Massachusetts, 02464, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kimberlee Trudeau, Ph. D.
Inflexxion, Inc.
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2014
First Posted
April 29, 2014
Study Start
September 1, 2014
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
July 27, 2015
Record last verified: 2015-06